In June 2023, we were designated as an accredited clinical specimen analysis laboratory by the Ministry of Food and Drug Safety.

We contribute to strengthening the competitiveness of domestic clinical trials by providing highly reliable analytical services.

In May 2024, we obtained certification of compliance with the Good Manufacturing Practice (GMP) standards for the manufacture and quality control of in vitro diagnostic medical devices intended for clinical performance testing from the Ministry of Food and Drug Safety, thereby establishing a quality management system.

In accordance with Article 10 of the Act on Bioethics and Safety and Article 6, Paragraph 3 of the Enforcement Rules of the same Act, we have completed the registration of an Institutional Bioethics Committee, thereby securing a research execution system that meets ethical and legal standards for research involving human subjects.

In accordance with Articles 5 and 11 of the “In Vitro Diagnostic Medical Devices Act” and Articles 9 and 26 of the Enforcement Rules of the same Act, we have completed the notification of manufacture for in vitro diagnostic medical devices and are establishing a quality and production system based on the relevant regulations.

Registration number RR-BLDS-100

Certification number SG PSB-BT-06292 (TÜV SÜD)

Authentication number XU102612-25018

Certification number SG PSB-BT-06336 (TÜV SÜD)

Authentication number XU101635-25082